Publications

Goulet, JL, Griffiths, RC, Ruiz, P, Mannon, RB, Flannery, P, Platt, JL, Koller, BH, and Coffman, TM. "Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice." J Immunol 167, no. 11 (December 1, 2001): 6631-6636.

PMID
11714834
Scholars@Duke

Athirakul, K, Kim, HS, Audoly, LP, Smithies, O, and Coffman, TM. "Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition." Kidney Int 60, no. 6 (December 2001): 2324-2329.

PMID
11737606
Full Text

Svenson, IK, Ashley-Koch, AE, Pericak-Vance, MA, and Marchuk, DA. "A second leaky splice-site mutation in the spastin gene." Am J Hum Genet 69, no. 6 (December 2001): 1407-1409. (Letter)

PMID
11704932
Full Text

Buhimschi, IA, Hall, G, Thompson, LP, and Weiner, CP. "Pregnancy and estradiol decrease GTPase activity in the guinea pig uterine artery." American journal of physiology. Heart and circulatory physiology 281, no. 5 (November 2001): H2168-H2175.

PMID
11668079
Full Text

Butterly, DW, and Schwab, SJ. "Catheter access for hemodialysis: an overview." Semin Dial 14, no. 6 (November 2001): 411-415. (Review)

PMID
11851925
Scholars@Duke

Svetkey, LP, Moore, TJ, Simons-Morton, DG, Appel, LJ, Bray, GA, Sacks, FM, Ard, JD, Mortensen, RM, Mitchell, SR, Conlin, PR, Kesari, M, and DASH collaborative research group, . "Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study." J Hypertens 19, no. 11 (November 2001): 1949-1956.

PMID
11677359
Scholars@Duke

Peri, UN, Fenves, AZ, and Middleton, JP. "Improving survival of octogenarian patients selected for haemodialysis." Nephrol Dial Transplant 16, no. 11 (November 2001): 2201-2206.

PMID
11682668
Scholars@Duke

Obarzanek, E, Proschan, MA, Moore, TJ, Sacks, FM, Svetkey, LP, Appel, LJ, Vollmer, WM, Most-Windhauser, MM, and Cutler, JA. "Variability in blood pressure response to salt intake." CIRCULATION 104, no. 17 (October 23, 2001): 811-812.

Scholars@Duke

Ellis, MJ, Emani, SM, Colgrove, SL, Glower, DD, and Taylor, DA. "Cell dosage is critical for improved contractility following cellular cardiomyoplasty." October 23, 2001.

Scholars@Duke

Aston, AG, Emani, SM, Pineles, SL, Colgrove, SL, Ellis, MJ, and Taylor, DA. "Genetically engineered myoblasts survive allogeneic transplant into myocardium." CIRCULATION 104, no. 17 (October 23, 2001): 324-324.

Scholars@Duke

Pages